Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation.

Sjöberg B, Qureshi AR, Anderstam B, Alvestrand A, Bárány P.

Blood Purif. 2012;34(3-4):290-7. doi: 10.1159/000342630. Epub 2012 Dec 7.

PMID:
23235124
2.

Combined hypertriglyceridemic and insulin-glucose clamps for the characterization of substrate oxidation and plasma elimination of a long-chain triglyceride emulsion in healthy men.

Åberg V, Thörne A, Alvestrand A, Nordenström J.

Metabolism. 2012 Feb;61(2):221-8. doi: 10.1016/j.metabol.2011.06.011. Epub 2011 Aug 23.

PMID:
21864866
3.

Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study.

Alvestrand A, Ledebo I, Hagerman I, Wingren K, Mattsson E, Qureshi AR, Gutierrez A.

Blood Purif. 2011;32(1):21-9. doi: 10.1159/000323140. Epub 2011 Jan 21.

PMID:
21252503
4.

Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease.

Miyamoto T, Rashid Qureshi A, Yamamoto T, Nakashima A, Lindholm B, Stenvinkel P, Alvestrand A, Axelsson J.

Nephrol Dial Transplant. 2011 Jul;26(7):2231-7. doi: 10.1093/ndt/gfq697. Epub 2010 Nov 23.

PMID:
21098658
5.

Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.

Matsubara K, Stenvinkel P, Qureshi AR, Carrero JJ, Axelsson J, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Suliman ME.

J Nephrol. 2009 Nov-Dec;22(6):774-82.

PMID:
19967657
6.

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.

Am J Kidney Dis. 2009 Jun;53(6):1024-33. doi: 10.1053/j.ajkd.2009.02.008. Epub 2009 Apr 25.

PMID:
19394732
7.

Proteome patterns in uremic plasma.

Naseeb U, Shafqat J, Jägerbrink T, Zarina S, Alvestrand A, Jörnvall H, Axelsson J.

Blood Purif. 2008;26(6):561-8. doi: 10.1159/000178773. Epub 2008 Dec 2.

PMID:
19052450
8.

[Protein-restricted diet good in uremia. Safe, cost-effective--and underused--treatment method].

Alvestrand A.

Lakartidningen. 2008 Jul 23-Aug 5;105(30-31):2084-5. Swedish. No abstract available.

PMID:
18751445
9.

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P.

Clin J Am Soc Nephrol. 2008 Jul;3(4):976-85. doi: 10.2215/CJN.03960907. Epub 2008 Apr 16.

10.

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.

Suliman ME, Qureshi AR, Carrero JJ, Bárány P, Yilmaz MI, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P.

QJM. 2008 May;101(5):397-405. doi: 10.1093/qjmed/hcn019. Epub 2008 Feb 20.

PMID:
18292098
11.

Acute effects of low and high intravenous doses of furosemide on myocardial function in anuric haemodialysis patients: a tissue Doppler study.

Hayashi SY, Seeberger A, Lind B, Gunnes S, Alvestrand A, do Nascimento MM, Lindholm B, Brodin LA.

Nephrol Dial Transplant. 2008 Apr;23(4):1355-61. Epub 2007 Nov 29.

PMID:
18048421
12.

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.

Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, Bárány P, Heimbürger O, Suliman ME, Alvestrand A, Lindholm B, Stenvinkel P.

J Intern Med. 2007 Dec;262(6):690-701. Epub 2007 Oct 1.

13.

Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.

Stenvinkel P, Rodríguez-Ayala E, Massy ZA, Qureshi AR, Barany P, Fellström B, Heimburger O, Lindholm B, Alvestrand A.

Clin J Am Soc Nephrol. 2006 Mar;1(2):281-7. Epub 2006 Feb 1.

14.

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.

Tong M, Carrero JJ, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Axelsson J, Alvestrand A, Stenvinkel P, Lindholm B, Suliman ME.

Clin J Am Soc Nephrol. 2007 Sep;2(5):889-97. Epub 2007 Aug 16.

15.

Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?

Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimbürger O, Barany P, Alvestrand A, Nordfors L, Qureshi AR, Ekström TJ, Schalling M.

J Intern Med. 2007 May;261(5):488-99.

16.

Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite.

Carrero JJ, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Kato S, Bárány P, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P.

Am J Clin Nutr. 2007 Mar;85(3):695-701.

PMID:
17344489
17.

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

Valli A, Suliman ME, Meert N, Vanholder R, Lindholm B, Stenvinkel P, Watanabe M, Barany P, Alvestrand A, Anderstam B.

Clin Chim Acta. 2007 Apr;379(1-2):87-94. Epub 2007 Jan 16.

PMID:
17292872
18.

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.

Am J Kidney Dis. 2007 Feb;49(2):237-44.

PMID:
17261426
19.

Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.

Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK, Stenvinkel P.

Am J Kidney Dis. 2006 Dec;48(6):916-25.

PMID:
17162146
20.

Effect of bicarbonate on muscle protein in patients receiving hemodialysis.

Löfberg E, Gutierrez A, Anderstam B, Wernerman J, Bergström J, Price SR, Mitch WE, Alvestrand A.

Am J Kidney Dis. 2006 Sep;48(3):419-29.

PMID:
16931215
21.

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.

Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P.

Kidney Int. 2006 Feb;69(3):596-604.

22.

Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.

Sjöberg B, Anderstam B, Suliman M, Alvestrand A.

Am J Kidney Dis. 2006 Jan;47(1):60-71.

PMID:
16377386
23.

Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging.

Hayashi SY, Rohani M, Lindholm B, Brodin LA, Lind B, Barany P, Alvestrand A, Seeberger A.

Nephrol Dial Transplant. 2006 Jan;21(1):125-32. Epub 2005 Oct 12.

PMID:
16221719
24.

Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease.

Suliman ME, Qureshi AR, Stenvinkel P, Pecoits-Filho R, Bárány P, Heimbürger O, Anderstam B, Rodríguez Ayala E, Divino Filho JC, Alvestrand A, Lindholm B.

Am J Clin Nutr. 2005 Aug;82(2):342-9.

PMID:
16087977
25.

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.

Suliman ME, Stenvinkel P, Qureshi AR, Bárány P, Heimburger O, Anderstam B, Alvestrand A, Lindholm B.

Am J Kidney Dis. 2004 Sep;44(3):455-65.

PMID:
15332218
26.

Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging.

Hayashi SY, Brodin LA, Alvestrand A, Lind B, Stenvinkel P, Mazza do Nascimento M, Qureshi AR, Saha S, Lindholm B, Seeberger A.

Nephrol Dial Transplant. 2004 Jun;19(6):1497-506. Epub 2004 Mar 19.

PMID:
15034157
27.

Environmental lead exposure and chronic renal disease.

Elinder CG, Alvestrand A.

N Engl J Med. 2003 May 1;348(18):1810-2; author reply 1810-2. No abstract available.

PMID:
12728912
28.

Inflammation in end-stage renal disease: sources, consequences, and therapy.

Stenvinkel P, Alvestrand A.

Semin Dial. 2002 Sep-Oct;15(5):329-37. Review.

PMID:
12358637
29.

Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle.

Löfberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, Bergström J, Alvestrand A.

Eur J Clin Invest. 2002 May;32(5):345-53.

PMID:
12027875
30.

Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.

Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimbürger O, Lindholm B, Bergström J.

J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S28-36.

31.

Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers.

Bárány P, Stenvinkel P, Ottosson-Seeberger A, Alvestrand A, Morrow J, Roberts JJ 2nd, Salahudeen AK.

Nephrol Dial Transplant. 2001 Mar;16(3):580-4.

PMID:
11239035
32.

Effect of hemodialysis on protein synthesis.

Löfberg E, Essén P, McNurlan M, Wernerman J, Garlick P, Anderstam B, Bergström J, Alvestrand A.

Clin Nephrol. 2000 Oct;54(4):284-94.

PMID:
11076104
33.

LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion.

Stenvinkel P, Alvestrand A, Angelin B, Eriksson M.

Eur J Clin Invest. 2000 Oct;30(10):866-70.

PMID:
11029600
34.

Amino acid concentration in the interstitium of human skeletal muscle: a microdialysis study.

Gutierrez A, Anderstam B, Alvestrand A.

Eur J Clin Invest. 1999 Nov;29(11):947-52.

PMID:
10583439
35.

Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients.

Ottosson-Seeberger A, Ahlborg G, Hemsén A, Lundberg JM, Alvestrand A.

J Am Soc Nephrol. 1999 May;10(5):1037-44.

36.

[Should surgery of inguinal hernia be performed by human "machines"?].

Alvestrand A.

Lakartidningen. 1998 Aug 5;95(32-33):3391-2. Swedish. No abstract available.

PMID:
9725943
37.

A luminometric assay for determination of ethanol in microdialysates.

Anderstam B, Gutierrez A, Lundin A, Alvestrand A.

Scand J Clin Lab Invest. 1998 Feb;58(1):89-96.

PMID:
9516661
38.

Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.

Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergström J.

Kidney Int. 1998 Mar;53(3):773-82.

39.

Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans.

Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G.

Acta Physiol Scand. 1997 Oct;161(2):211-20.

PMID:
9366964
40.

Carbohydrate and insulin metabolism in renal failure.

Alvestrand A.

Kidney Int Suppl. 1997 Nov;62:S48-52. Review. No abstract available.

PMID:
9350680
41.

A calcium-channel blocker, amlodipine, attenuates insulin antinatriuresis but does not modulate insulin-mediated attenuation of cardiovascular reactivity in healthy man.

Stenvinkel P, Ottosson-Seeberger A, de Potocki K, Alvestrand A.

Nephrol Dial Transplant. 1997 Aug;12(8):1600-7.

PMID:
9269636
43.

Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.

Stenvinkel P, Berglund L, Ericsson S, Alvestrand A, Angelin B, Eriksson M.

Eur J Clin Invest. 1997 Feb;27(2):169-77.

PMID:
9061312
44.

Relationship between nitrogen balance, protein, and energy intake in haemodialysis patients.

Alvestrand A, Gutierrez A.

Nephrol Dial Transplant. 1996;11 Suppl 2:130-3. Review. No abstract available.

PMID:
8804013
45.

Nutritional aspects in patients with acute renal failure/multiorgan failure.

Alvestrand A.

Blood Purif. 1996;14(1):109-14. Review.

PMID:
8718574
46.

Effect of insulin on renal sodium handling and renal haemodynamics in insulin-dependent (type 1) diabetes mellitus patients.

Stenvinkel P, Ottosson-Seeberger A, Alvestrand A, Bolinder J.

Acta Diabetol. 1995 Dec;32(4):230-4.

PMID:
8750761
47.

Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia.

Stenvinkel P, Ottosson-Seeberger A, Alvestrand A.

J Am Soc Nephrol. 1995 Apr;5(10):1751-60.

48.

Nutritional status, muscle composition and plasma and muscle free amino acids in renal transplant patients.

Qureshi AR, Lindholm B, Alvestrand A, Bergström J, Tollemar J, Hultman E, Groth CG.

Clin Nephrol. 1994 Oct;42(4):237-45.

PMID:
7834916
49.

Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid.

Gutierrez A, Bergström J, Alvestrand A.

Kidney Int. 1994 Sep;46(3):814-22.

50.

Biocompatibility of hemodialysis membranes: a study in healthy subjects.

Gutierrez A, Alvestrand A, Bergström J, Beving H, Lantz B, Henderson LW.

Blood Purif. 1994;12(2):95-105.

PMID:
7826580

Supplemental Content

Loading ...
Support Center